FLPIM
ALNY icon

F.L. Putnam Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

F.L. Putnam Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$831K Buy
2,761
+20
+0.7% +$6.03K 0.01% 398
2026
Q1 		$907K Buy
+2,741
New +$933K 0.01% 340

Other funds holding ALNY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

F.L. Putnam Investment Management's ALNY Position: Q2 2026 in Review

F.L. Putnam Investment Management increased its Alnylam Pharmaceuticals (ALNY) stake by 0.73% in Q2 2026, buying an estimated $6.03K and bringing the position to 2,761 shares worth $831K. The position accounts for 0.01% of the portfolio, ranked #398.

F.L. Putnam Investment Management first reported a position in ALNY in Q1 2026 and has held it in 2 quarters since. The position peaked at $907K in Q1 2026. 404 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • F.L. Putnam Investment Management held 2,761 shares of Alnylam Pharmaceuticals worth $831K as of Q2 2026.
  • F.L. Putnam Investment Management bought 20 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $6.03K.
  • Alnylam Pharmaceuticals made up 0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #398 holding.
  • F.L. Putnam Investment Management first reported a position in Alnylam Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • F.L. Putnam Investment Management's Alnylam Pharmaceuticals position peaked at $907K in Q1 2026.
  • 404 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.